Key result
Transapical access for TEVAR achieves complete aneurysm exclusion without endoleak in all 3 patients.
Why the study?
Is the transapical approach for TEVAR feasible and safe in patients with thoracic aortic aneurysms and inaccessible femoral arteries?
Population
3 patients with thoracic aortic aneurysms with inaccessible femoral arteries
Design
Case_series
Follow-up
Up to 43 days
Authors
Loading...
May support transapical TEVAR feasibility with inaccessible femoral access; hypothesis-generating for safety and durability in larger cohorts.
Case Report (n=3)
Is the transapical approach for TEVAR feasible and safe in patients with thoracic aortic aneurysms and inaccessible femoral arteries?
The transapical approach for TEVAR is technically feasible in patients with inaccessible femoral arteries, though significant complications can occur.
Mahnken et al. (2017) conducted a case report in Thoracic aortic aneurysms (n=3). Transapical access for TEVAR was evaluated on Technical success with complete exclusion of the aneurysm without endoleak. Transapical access for TEVAR was technically successful in all 3 patients, achieving complete exclusion of the aneurysm without endoleak.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: